Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Boron Chemicals in Drug Discovery and Development: Synthesis and Medicinal Perspective

Molecules(2022)10.3390/molecules27092615Source: DataRank Database

Boron Chemicals in Drug Discovery and Development: Synthesis and Medicinal Perspective is a research paper published in Molecules (2022). On theSindex it has a DataRank of 0. It has been cited 136 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access136 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 15.23)OA: goldTopics (50)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Nitesh Kumar Nandwana ORCID,Sasmita Das ORCID,Varsha Nandwana,Mohd Adil Shareef ORCID,Yogarupa Das

Live enrichment

PubMed:35565972 OpenAlex:https://openalex.org/W4224222753

National Institutes of Health

Grant: R01AI132614-01A1, R21 AA027374-01, 1R01NS109423-01A1

National Institutes of Health

Grant: 3R21AA027374-02S1

Receptor Specific Retinoids Probes to Study the Brain Damage Caused by Developmental Alcohol Exposure

National Institutes of Health

Grant: 3R01AI132614-04S1

Development of Novel MetAP2 inhibitors as potential therapeutics for Microsporidiosis

National Institutes of Health

Grant: 1R01NS109423-01A1

Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma

NIAID NIH HHS

Grant: R01 AI132614

NINDS NIH HHS

Grant: R01 NS109423

NIAAA NIH HHS

Grant: R21 AA027374

FWCI

15.23

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3390/molecules27092615

publisherhttps://doi.org/10.3390/molecules27092615

publisherhttps://www.mdpi.com/1420-3049/27/9/2615/pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35565972

repositoryhttps://doaj.org/article/465a4b6712a346e6a0f57401db52b09e

Fields of Study

Boron Compounds in ChemistryOrganoboron and organosilicon chemistryPeptidase Inhibition and Analysis0301 basic medicine0303 health sciences03 medical and health sciencesBoranesBoronBoron CompoundsBortezomibDrug DiscoveryEnzyme InhibitorsHumans

MeSH Terms

BortezomibBoranesBoronBoron CompoundsEnzyme InhibitorsHumansDrug Discovery

Keywords

AntiprotozoalDrugDrug discoveryPharmacologyChemistryDrug developmentAntiparasitic agentAntiparasiticAntimicrobialCombinatorial chemistryBiochemistryMedicineOrganic chemistryIn vitroBoron CompoundsReviewBortezomibQD241-441boron-containing drugsboron-containing retinoidslipogenic inhibitorsHumansaminoboronic acidsbezoxaborolesALSEnzyme InhibitorsBoranesBoronbrain cancerproteasome inhibitors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being